{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:27:39Z","timestamp":1697002059700},"reference-count":117,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1053\/j.jrn.2006.01.011","type":"journal-article","created":{"date-parts":[[2006,3,28]],"date-time":"2006-03-28T15:14:18Z","timestamp":1143558858000},"page":"87-99","source":"Crossref","is-referenced-by-count":15,"title":["New Therapies for Uremic Secondary Hyperparathyroidism"],"prefix":"10.1053","volume":"16","author":[{"given":"Pablo Ure\u00f1a","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Pri\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2006.01.011_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.01.011_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2006.01.011_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib4","first-page":"219","article-title":"Mechanisms through which parathyroid homone mediates its deleterious effects on organ function in uremia","volume":"14","author":"Massry","year":"1994","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1073-4449(97)70030-X","article-title":"Cardiac disease in chronic uremia","volume":"4","author":"Amann","year":"1997","journal-title":"Adv Ren Replace Ther"},{"key":"10.1053\/j.jrn.2006.01.011_bib7","first-page":"2043","article-title":"Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia","volume":"10","author":"Amann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0008-6363(00)00130-9","article-title":"Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy","volume":"47","author":"Kosch","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jrn.2006.01.011_bib9","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.01.011_bib11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1681\/ASN.V341008","article-title":"Short and long-term efficacity of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients","volume":"3","author":"Gagn\u00e9","year":"1992","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/12.1.16","article-title":"How important is vitamin D deficiency in uraemia?","volume":"12","author":"Cunningham","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(76)91140-5","article-title":"Vitamin-D deficiency in the osteomalacia of chronic renal failure","volume":"1","author":"Eastwood","year":"1976","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2006.01.011_bib14","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1046\/j.1523-1755.1999.00480.x","article-title":"Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser\u2019s zones independent of calcitriol?","volume":"55","author":"Ghazali","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.ajkd.2005.02.029","article-title":"Prevalence of calcidiol deficiency in CKD","volume":"45","author":"LaClair","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.01.011_bib16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/en.136.4.1419","article-title":"The role of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands","volume":"136","author":"Brown","year":"1995","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2006.01.011_bib17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ki.1994.138","article-title":"Regulation of calcitriol receptor and its mRNA in normal and renal failure rats","volume":"1994","author":"Patel","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","article-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality","volume":"15","author":"Stevens","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib19","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib20","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1053\/ajkd.2001.20741","article-title":"Control of secondary hyperparathyroidism by vitamin D derivatives","volume":"37","author":"Drueke","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.01.011_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/ki.1993.280","article-title":"Effect of 22-oxa-calcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism","volume":"44","author":"Kubrusly","year":"1993","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib22","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","article-title":"Mechanisms of secondary hyperparathyroidism","volume":"283","author":"Silver","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.jrn.2006.01.011_bib23","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1681\/ASN.V86993","article-title":"Considerations for the treatment of secondary hyperparathyroidism in renal failure","volume":"8","author":"Felsenfeld","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib24","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1046\/j.1523-1755.1999.07316.x","article-title":"Hyperphosphatemia in end-stage renal disease patients","volume":"73","author":"Llach","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2006.01.011_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000187162","article-title":"In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol","volume":"63","author":"Aparicio","year":"1993","journal-title":"Nephron"},{"key":"10.1053\/j.jrn.2006.01.011_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-139X.1998.tb00363.x","article-title":"Current and future therapies for the medical management of secondary hyperparathyroidism","volume":"11","author":"Chertow","year":"1998","journal-title":"Sem Dial"},{"key":"10.1053\/j.jrn.2006.01.011_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0300-2977(99)00084-4","article-title":"Efficacy and tolerance of three different calcium acetate formulations in hemodialysis patients","volume":"55","author":"vandenBergh","year":"1999","journal-title":"Neth J Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib28","doi-asserted-by":"crossref","first-page":"c8","DOI":"10.1159\/000084653","article-title":"Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia","volume":"100","author":"Hutchison","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2006.01.011_bib29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1172\/JCI105530","article-title":"The effect of treatment of acidosis on calcium balance in patients with chronic azotemic renal disease","volume":"46","author":"Litzow","year":"1967","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2006.01.011_bib30","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1046\/j.1523-1755.2000.00086.x","article-title":"Effect of metabolic acidosis on the growth hormone\/IGF-I endocrine axis in skeletal growth centers","volume":"57","author":"Green","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI108962","article-title":"Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis","volume":"61","author":"McSherry","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2006.01.011_bib32","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/ki.1989.309","article-title":"Optimal correction of acidosis changes progression of dialysis osteodystrophy","volume":"36","author":"Lefebvre","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.2000.01081.x","article-title":"Reduced vitamin D receptor expression in parathyroid adenomas","volume":"53","author":"Sudhaker Rao","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1053\/j.jrn.2006.01.011_bib34","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","article-title":"Targeted ablation of the vitamin D receptor","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jrn.2006.01.011_bib35","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1210\/en.139.10.4391","article-title":"Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice","volume":"139","author":"Li","year":"1998","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2006.01.011_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jsbmb.2004.03.058","article-title":"Effects of calcium and of the Vitamin D system on skeletal and calcium homeostasis","volume":"89-90","author":"Goltzman","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1053\/j.jrn.2006.01.011_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1359\/jbmr.2001.16.1.46","article-title":"25-hydroxyvitamin D 1 alpha-hydroxylase","volume":"16","author":"Panda","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.jrn.2006.01.011_bib38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib39","first-page":"F454","article-title":"Rat calcium-sensing receptor is regulated by vitamin D but not by calcium","volume":"270","author":"Brown","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2006.01.011_bib40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/me.10.5.555","article-title":"Calcium-sensing receptor expression and regulation by extracellular calcium in the AtT-20 pituitary cell line","volume":"10","author":"Rodica","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1053\/j.jrn.2006.01.011_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/gcen.1999.7405","article-title":"Expression of calcium-sensing receptor gene by avian parathyroid gland in vivo","volume":"117","author":"Yarden","year":"2000","journal-title":"Gen Comp Endocrinol"},{"key":"10.1053\/j.jrn.2006.01.011_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0002-9343(98)00418-5","article-title":"Physiology and pathophysiology of the extracellular calcium-sensing receptor","volume":"106","author":"Brown","year":"1999","journal-title":"Am J Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib43","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1097\/01.ASN.0000141016.20133.33","article-title":"Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency","volume":"15","author":"Mizobuchi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/joe.0.1530437","article-title":"Ca2+ receptor mRNA and protein increase in the rat parathryoid gland with advancing age","volume":"153","author":"Autry","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1053\/j.jrn.2006.01.011_bib45","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1006\/bbrc.1997.7207","article-title":"Inhibition of PTH secretion by interleukin-1 beta in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium- sensing receptor mRNA","volume":"238","author":"Nielsen","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.jrn.2006.01.011_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/jcem-46-2-267","article-title":"Dispersed cells prepared from human parathyroid glands","volume":"46","author":"Brown","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2006.01.011_bib47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0002-9343(79)90446-7","article-title":"Calcium-regulated parathyroid hormone release in primary hyperparathyroidism","volume":"66","author":"Brown","year":"1979","journal-title":"Am J Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jcem-54-1-172","article-title":"Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure","volume":"54","author":"Brown","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2006.01.011_bib49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1172\/JCI109145","article-title":"Responsiveness of neoplastic and hyperplastic parathyroid tissue to calcium in vitro","volume":"62","author":"Habener","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2006.01.011_bib50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ndt\/11.supp3.136","article-title":"The PTH-calcium relationship curve in secondary hyperparathyroidism, an index of sensitivity and suppressibility of parathyroid glands","volume":"11","author":"Caligara","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib51","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1210\/jc.83.11.3839","article-title":"The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure","volume":"83","author":"Cardinal","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2006.01.011_bib52","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/ki.1994.473","article-title":"Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients","volume":"46","author":"Messa","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.1996.31","article-title":"The set point of calcium and the reduction of parathyroid hormone in hemodialysis patients","volume":"49","author":"Pahl","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib54","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/jc.76.6.1489","article-title":"Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism","volume":"76","author":"Ramirez","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2006.01.011_bib55","first-page":"E961","article-title":"Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism","volume":"267","author":"Ramirez","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jrn.2006.01.011_bib56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5414\/CNP61253","article-title":"PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method","volume":"61","author":"Schindler","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib57","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium","volume":"83","author":"Delmez","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2006.01.011_bib58","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ki.1989.305","article-title":"Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis","volume":"36","author":"Dunlay","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1677\/joe.1.05565","article-title":"The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve","volume":"184","author":"Bas","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1053\/j.jrn.2006.01.011_bib60","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1359\/jbmr.1997.12.3.347","article-title":"Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism","volume":"12","author":"Rodriguez","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.jrn.2006.01.011_bib61","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","article-title":"Calcimimetics with potent and selective activity on the parathyroid calcium receptor","volume":"95","author":"Nemeth","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.jrn.2006.01.011_bib62","first-page":"1083","article-title":"Allosteric activation of the Ca2+ receptor in xenopus laevis oocytes by NPS 467 or NPS 568","volume":"53","author":"Hammerland","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1053\/j.jrn.2006.01.011_bib63","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N, Engl J Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib64","first-page":"573A","article-title":"Single doses of the calcimimetic AMG-073 reduce parathyroid hormone levels in a dose dependent manner in hemodialysis patients with secondary hyperparathyroidism","volume":"11","author":"Coburn","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ki.1989.170","article-title":"Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia","volume":"36","author":"Ure\u00f1a","year":"1989","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib66","first-page":"SA-P073","article-title":"Down-regulation of Ca2+ transporters in kidney and duodenum by the calcimimetic compound NPS R-467","volume":"14","author":"Van Abel","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib67","first-page":"764A","article-title":"Short-term treatment of secondary hyperparathyroidism (SHTP) with the calcimimetic agent AMG 073","volume":"12","author":"Drueke","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib68","series-title":"Sustained control of uraemic secondary hyperparathyroidism (SHPT) after three years of treatment with the calcimimetic Cinacalcet HCL","author":"Urena","year":"2003"},{"key":"10.1053\/j.jrn.2006.01.011_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib70","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG 073 reduces parathyroid hormone and calcium \u00d7 phosphorus in secondary hyperparathyroidism","volume":"63","author":"Lindberg","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib71","first-page":"280A","article-title":"Cinacalcet HCL (Sensipar) for the management of secondary hyperparathyroidism in study patients receiving peritoneal dialysis","volume":"15","author":"Mittman","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib72","series-title":"Cinacalcet HCL in secondary hyperparathyroidism. Official Evening Symposium of the American Society of Nephrology (ASN)","author":"Bushinsky","year":"2004"},{"key":"10.1053\/j.jrn.2006.01.011_bib73","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCL","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib74","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","article-title":"Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCL","volume":"20","author":"Moe","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib75","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCL on cardiovascular disease, fracture and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib76","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","article-title":"Natural history of parathyroid function and calcium metabolism after kidney transplantation","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib77","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","article-title":"The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism","volume":"20","author":"Kruse","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib78","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","article-title":"Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism","volume":"20","author":"Serra","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib79","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199711203372104","article-title":"Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism","volume":"337","author":"Silverberg","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib80","first-page":"F497","article-title":"Clinical course of 10 patients with inoperable parathyroid carcinoma treated with the calcimimetic cinacalcet HCL","author":"Rubin","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.jrn.2006.01.011_bib81","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2003-031054","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism","volume":"89","author":"Kifor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2006.01.011_bib82","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.81.4.1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2006.01.011_bib83","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa040008","article-title":"Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor","volume":"351","author":"Pallais","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib84","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/S0140-6736(98)09089-8","article-title":"Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism","volume":"353","author":"Hindie","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2006.01.011_bib85","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1148\/radiology.207.1.9580138","article-title":"Secondary hyperparathyroidism","volume":"207","author":"Jeanguillaume","year":"1998","journal-title":"Radiology"},{"key":"10.1053\/j.jrn.2006.01.011_bib86","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00309231","article-title":"Factors related to the recurrent hyperfunction of autografts after total parathyroidectomy in patients with severe secondary hyperparathyroidism","volume":"23","author":"Tanaka","year":"1993","journal-title":"Surg Today"},{"issue":"suppl 3","key":"10.1053\/j.jrn.2006.01.011_bib87","first-page":"65","article-title":"Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients","volume":"18","author":"Tominaga","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib88","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archsurg.135.12.1461","article-title":"Unilateral surgery for primary hyperparathyroidism on the basis of technetium Tc 99m sestamibi and iodine 123 subtraction scanning","volume":"135","author":"Hindie","year":"2000","journal-title":"Arch Surg"},{"key":"10.1053\/j.jrn.2006.01.011_bib89","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/BF03347249","article-title":"Parathyroid surgery","volume":"28","author":"Miccoli","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"suppl 3","key":"10.1053\/j.jrn.2006.01.011_bib90","first-page":"31","article-title":"Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","volume":"18","author":"Fukagawa","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib91","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1755.2003.00154.x","article-title":"Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia","volume":"64","author":"Shiizaki","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.2004030236","article-title":"Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats","volume":"16","author":"Shiizaki","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"suppl 3","key":"10.1053\/j.jrn.2006.01.011_bib93","first-page":"42","article-title":"Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients","volume":"18","author":"Shiizaki","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2006.01.011_bib94","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","article-title":"p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium","volume":"60","author":"Cozzolino","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib95","doi-asserted-by":"crossref","first-page":"F1096","DOI":"10.1152\/ajprenal.00167.2005","article-title":"A critical role for enhanced-TGF \u03b1 and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease","volume":"289","author":"Cozzolino","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.jrn.2006.01.011_bib96","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0006-291X(91)91884-F","article-title":"The 5\u2032-triphosphates of 3\u2032-azido-3\u2032-deoxythymidine and 2\u2032, 3\u2032-dideoxynucleosides inhibit DNA polymerase gamma by different mechanisms","volume":"179","author":"Izuta","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.jrn.2006.01.011_bib97","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1359\/JBMR.041123","article-title":"Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture","volume":"20","author":"Falchetti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.jrn.2006.01.011_bib98","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/me.2004-0108","article-title":"The protein phosphatase calcineurin determines basal parathyroid hormone gene expression","volume":"19","author":"Bell","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1053\/j.jrn.2006.01.011_bib99","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1523-1755.2005.00493.x","article-title":"Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism","volume":"68","author":"D\u2019Amour","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib100","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/en.2004-1262","article-title":"Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells","volume":"146","author":"Divieti","year":"2005","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2006.01.011_bib101","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/en.143.1.171","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"key":"10.1053\/j.jrn.2006.01.011_bib102","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2003-0024","article-title":"Parathyroid hormone secretion and action","volume":"26","author":"Murray","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1053\/j.jrn.2006.01.011_bib103","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2006.01.011_bib104","doi-asserted-by":"crossref","first-page":"c93","DOI":"10.1159\/000080680","article-title":"Intravenous vitamin D therapy reduces PTH-(1-84)\/large C fragments ratio in chronic hemodialysis patients","volume":"98","author":"Kihara","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2006.01.011_bib105","first-page":"279A","article-title":"Treatment of severe hyperparathyroidism secondary to parathyroid cancer with ABX10241, a fully human monoclonal antibody directed against parathyroid hormone","volume":"15","author":"Pollock","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2006.01.011_bib106","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2006.01.011_bib107","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/105072502760339352","article-title":"Calcitonin","volume":"12","author":"Inzerillo","year":"2002","journal-title":"Thyroid"},{"key":"10.1053\/j.jrn.2006.01.011_bib108","first-page":"117","article-title":"Medical treatment in primary and secondary hyperparathyroidism","volume":"2","author":"Coburn","year":"1972","journal-title":"Semin Drug Treat"},{"issue":"suppl","key":"10.1053\/j.jrn.2006.01.011_bib109","first-page":"725","article-title":"[Calcitonin for therapy of renal osteodystrophy due to long- term hemodialysis in patients with chronic kidney failure]","volume":"49","author":"Ishida","year":"1991","journal-title":"Nippon Rinsho"},{"key":"10.1053\/j.jrn.2006.01.011_bib110","first-page":"797","article-title":"[Effect of salmon calcitonin on bone mineral density and calcium- phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism]","volume":"112","author":"Matuszkiewicz-Rowinska","year":"2004","journal-title":"Pol Arch Med Wewn"},{"key":"10.1053\/j.jrn.2006.01.011_bib111","first-page":"23","article-title":"[Combined therapy with calcitonin and high doses of active vitamin D3 metabolites in uremic hyperparathyroidism]","volume":"96","author":"Matuszkiewicz-Rowinska","year":"1996","journal-title":"Pol Arch Med Wewn"},{"key":"10.1053\/j.jrn.2006.01.011_bib112","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1053\/j.jrn.2006.01.011_bib113","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1515\/CCLM.2002.177","article-title":"Increased levels of osteoprotegerin in hemodialysis patients","volume":"40","author":"Avbersek-Luznik","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib114","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.mnh.0000133982.40182.8a","article-title":"Osteoprotegerin and bone mineral metabolism in renal failure","volume":"13","author":"Kazama","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1053\/j.jrn.2006.01.011_bib115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(03)00655-3","article-title":"The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis","volume":"42","author":"Nitta","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2006.01.011_bib116","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa050893","article-title":"Recombinant osteoprotegerin for juvenil Paget\u2019s disease","volume":"353","author":"Cundy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jrn.2006.01.011_bib117","doi-asserted-by":"crossref","first-page":"15455","DOI":"10.1074\/jbc.270.26.15455","article-title":"Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor","volume":"270","author":"Usdin","year":"1995","journal-title":"J Biol Chem"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227606000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227606000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T06:42:01Z","timestamp":1627195321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227606000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1051227606000112"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2006.01.011","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}